Umbreen Hafeez

639 total citations · 1 hit paper
14 papers, 463 citations indexed

About

Umbreen Hafeez is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Umbreen Hafeez has authored 14 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Umbreen Hafeez's work include Glioma Diagnosis and Treatment (6 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Umbreen Hafeez is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Umbreen Hafeez collaborates with scholars based in Australia, United Kingdom and United States. Umbreen Hafeez's co-authors include Hui Gan, Andrew M. Scott, Sagun Parakh, Adam Parslow, Lawrence Cher, Priscilla K. Brastianos, Adithya Balasubramanian, Ashray Gunjur, Franziska M. Ippen and Ahmed H. Abdelhafiz and has published in prestigious journals such as Molecules, The Oncologist and Current Opinion in Pharmacology.

In The Last Decade

Umbreen Hafeez

14 papers receiving 456 citations

Hit Papers

Antibody–Drug Conjugates for Cancer Therapy 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antibody–Drug Conjugates for Cancer Therapy
    2020 278 citations Umbreen Hafeez, Sagun Parakh et al. Molecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umbreen Hafeez Australia 7 252 184 163 83 46 14 463
Marjolijn N. Lub‐de Hooge Netherlands 12 274 1.1× 345 1.9× 129 0.8× 79 1.0× 69 1.5× 25 516
Catherine Huang United States 10 249 1.0× 123 0.7× 177 1.1× 80 1.0× 36 0.8× 11 421
Latha Sridharan United States 10 367 1.5× 230 1.3× 222 1.4× 64 0.8× 30 0.7× 11 656
Shani L. Frayo United States 11 121 0.5× 286 1.6× 182 1.1× 58 0.7× 95 2.1× 23 530
Anneleen Blykers Belgium 6 168 0.7× 295 1.6× 138 0.8× 126 1.5× 38 0.8× 8 428
Wenxu Zhao China 7 171 0.7× 137 0.7× 176 1.1× 96 1.2× 24 0.5× 19 374
Chirayu Shah United States 10 298 1.2× 164 0.9× 156 1.0× 22 0.3× 67 1.5× 19 551
Alexander H. Staudacher Australia 15 443 1.8× 355 1.9× 225 1.4× 85 1.0× 141 3.1× 33 780
A Mayer United Kingdom 12 217 0.9× 162 0.9× 154 0.9× 68 0.8× 41 0.9× 16 548
Zhujun Jiang China 10 434 1.7× 183 1.0× 148 0.9× 330 4.0× 76 1.7× 16 689

Countries citing papers authored by Umbreen Hafeez

Since Specialization
Citations

This map shows the geographic impact of Umbreen Hafeez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umbreen Hafeez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umbreen Hafeez more than expected).

Fields of papers citing papers by Umbreen Hafeez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umbreen Hafeez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umbreen Hafeez. The network helps show where Umbreen Hafeez may publish in the future.

Co-authorship network of co-authors of Umbreen Hafeez

This figure shows the co-authorship network connecting the top 25 collaborators of Umbreen Hafeez. A scholar is included among the top collaborators of Umbreen Hafeez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umbreen Hafeez. Umbreen Hafeez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hafeez, Umbreen, et al.. (2024). Cancer Clinical Trial Participation Amongst Culturally and Linguistically Diverse Patients in Australia. Asia-Pacific Journal of Clinical Oncology. 21(1). 58–64. 1 indexed citations
2.
3.
Gan, Hui, Sagun Parakh, Laura D. Osellame, et al.. (2023). Antibody drug conjugates for glioblastoma: current progress towards clinical use. Expert Opinion on Biological Therapy. 23(11). 1089–1102. 3 indexed citations
4.
Gunjur, Ashray, Adithya Balasubramanian, Umbreen Hafeez, et al.. (2022). Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review. Journal of Neuro-Oncology. 159(3). 539–549. 11 indexed citations
5.
Gunjur, Ashray, Adithya Balasubramanian, Umbreen Hafeez, et al.. (2022). Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review. Journal of Neuro-Oncology. 159(3). 551–551. 1 indexed citations
6.
Hafeez, Umbreen, Adam Parslow, Hui Gan, & Andrew M. Scott. (2020). New insights into ErbB3 function and therapeutic targeting in cancer. Expert Review of Anticancer Therapy. 20(12). 1057–1074. 18 indexed citations
7.
Hafeez, Umbreen, Sagun Parakh, Hui Gan, & Andrew M. Scott. (2020). Antibody–Drug Conjugates for Cancer Therapy. Molecules. 25(20). 4764–4764. 278 indexed citations breakdown →
8.
Balasubramanian, Adithya, Ashray Gunjur, Umbreen Hafeez, et al.. (2020). Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma. Neuro-Oncology Advances. 3(1). vdaa171–vdaa171. 6 indexed citations
9.
Hafeez, Umbreen, Caroline Lum, Lawrence Cher, et al.. (2019). Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment. Journal of Clinical Neuroscience. 68. 45–50. 1 indexed citations
10.
Hafeez, Umbreen & Lawrence Cher. (2019). Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects. Neuro-Oncology Advances. 1(1). vdz013–vdz013. 2 indexed citations
11.
Hafeez, Umbreen, Hui Gan, & Andrew M. Scott. (2018). Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases. Current Opinion in Pharmacology. 41. 114–121. 116 indexed citations
12.
Brastianos, Priscilla K., Franziska M. Ippen, Umbreen Hafeez, & Hui Gan. (2018). Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies. The Oncologist. 23(9). 1063–1075. 10 indexed citations
13.
14.
Hafeez, Umbreen, et al.. (2010). Use of Multicompartment Compliance Aids for Elderly Patients: Patient Viewpoints and Hospital Length of Stay. Postgraduate Medicine. 122(4). 186–191. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjolijn N. Lub‐de Hooge Breakdown of academic impact, for papers by Catherine Huang Breakdown of academic impact, for papers by Latha Sridharan Breakdown of academic impact, for papers by Shani L. Frayo Breakdown of academic impact, for papers by Anneleen Blykers Breakdown of academic impact, for papers by Wenxu Zhao Breakdown of academic impact, for papers by Chirayu Shah Breakdown of academic impact, for papers by Alexander H. Staudacher Breakdown of academic impact, for papers by A Mayer Breakdown of academic impact, for papers by Zhujun Jiang
Rankless by CCL
2026